Behavioral Science Flashcards

1
Q

Retrospective case-control vs retrospective cohort

A

Case control compares a group with a disease and without a disease to look at exposures. End up with odds ratio (odds of getting disease with exposure vs without). Cohort study compares a group with a given exposure vs without, and sees how many developed disease. Looks at relative risk (risk of developing disease associated with exposure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Relative risk vs odds ratio

A

Relative risk is incidence exposed/incidence unexposed. Used is cohort study because have incidence data (new people who get disease in time period). Odds ratio, don’t have incidence because not looking over period of time, just whether they are a case or not. So have to do odds that group with disease was exposed to a risk factor/ odds that group without disease was exposed to risk factor. (Cases with exposure/ cases without exposure)/(noncases with exposure/ noncases without exposure). If prevalence is low, the two are about equal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Odds ratio for drug study

A

(Cases with treatment/ cases without treatment)/ (non-cases cases with treatment / noncases without treatment). Think of treatment as exposure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Phase I study: sample and purpose

A

Sample: small number of HEALTHY volunteer. Purpose: safety, toxicity, pharmacokinetics. Seeing how drug works on healthy people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phase II study: sample and purpose

A

Sample: Small number of PATIENTS with disease of interest. Assess: treatment efficacy, optimal dosing, and AE’s. Does the drug do what we want?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Phase III study: sample and purpose

A

Sample: Large number of patients randomly assigned to treatment or placebo (standard of care). Compares new treatment to current standard of care.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Phase IV: study sample and purpose

A

Postmarketing surveillance trial of patients after approval to detect rare or long-term AE’s.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Crossover study

A

Have placebo group and treatment group and then a washout period, then they switch. Allows people to serve as own controls.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sensitivity

A

TP/(TP+FN). 1- FN rate. Out of the people who have the disease, how many tested +? Can you pick it up? How good at you at finding positives? If you are bad, then a positive is more likely to be a true positive, and you’ll probs get a lot of false negatives.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Specificity

A

TN/(TN + FP). 1 - FP rate. Out of the people who don’t have the disease, how many tested -? If you pick it up, is it specific, or could it be something else? How good are you at finding negatives? If you are bad, then a negative is more likely to be a true negative, and you’ll probs get a lot of false positives.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PPV

A

TP/(TP + FP). Given that the test is positive, how likely is it that the person has the disease? Varies with prevalence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NPV

A

TN/(TN + FN). Given that the test is negative, how likely is it that the person doesn’t have the disease? Varies with prevalence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Relative risk

A

Risk of developing disease in exposed group/ risk of in unexposed group. (Exposed with disease/ total exposed)/(unexposed with disease/total unexposed). Compare with odds ratio: (exposed with/exposed w/o)/unexposed with/unexposed w/o). For RR we have prevalence, and thus can divide by the total. Use for cohort studies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Attributable risk

A

Difference in risk between exposed and unexposed. (Exposed with disease/total exposed) - (Unexposed with disease)/ total unexposed. Like RR except minussing instead of dividing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

You are given the RR and need to calculate the AR…

A

RR-1/RR. The math works out, trust me. You can do it out too if you want.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Absolute risk reduction

A

Now we are comparing treatment with control. Risk with treatment - risk without treatment. Absolute because not worried about what is attributable to the exposure, just looking at the change in risk overall.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Number needed to treat vs number needed to harm

A

Number needed to treat is number of patients who need to be treated for 1 to benefit. Number needed to harm is number of patients needed to be exposed for 1 to be harmed. 1/attributable risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Effect modification vs confounding

A

Effect modification is external variable impacts effect of risk factor on disease status. Ex: risk of smoking increases the risk of disease, but only for women. Vs. confounding, where being a woman increases both the risk for smoking AND risk of disease, so can’t tell if it is the smoking or being a woman causing the effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Precision vs accuracy

A

Precision = reliability, all trials have nearly same outcome. Accuracy = validity, how true the test is (bias?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Random error vs systematic error in changing precision and accuracy

A

Random error will change precision (will be different every time). Systematic error will change accuracy (won’t be as true)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Berkson’s bias

A

A selection bias from selecting hospitalized patients as a control. Think of Berks –> hospital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Late-look bias

A

Using a survey to study a fatal disease (only patients still alive will be able to answer). Gathering of info at inappropriate time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Procedure bias

A

Subjects in different groups not treated the same. For example, more attention is paid to treatment group, stimulating greater adherence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Lead-time bias

A

Early detection confused with increased survival. If doing a PSA and find prostate cancer, not surviving longer, just knowing about it longer.

25
Q

Hawthorne effect

A

When group being studied changes its behavior owing to the knowledge of being studied.

26
Q

Referral bias

A

Cases may be controls from all over referred to one place, controls are from actual place.

27
Q

Detection bias

A

Risk factor may actually increase chance of detection, skewing so more with disease have risk factor.

28
Q

Pigmalian effect

A

Researcher’s belief in efficacy of treatment can effect outcome. Also called observer-expectancy effect

29
Q

Normal distribution, positive/ negative skew: relationship between mean, median, mode

A

Normal: Mean = median = mode. Positive: Mean> median > mode. Negative: Mean < median < mode. If you imagine a skew, think of where the mode should be and the rest can be remembered by remembering the order, mean comes first, mode comes last, median in middle.

30
Q

Type 1 vs. Type II error

A

Type I = alpha. Stating that there is a difference when there totally isn’t one. p value is your alpha. Type II error = beta. Saying that there isn’t a difference but there totally is! Power = 1 - Beta

31
Q

Power

A

1-Beta. Probability of finding a difference when a difference exists. Increases with sample size, effect size, and precision of measurement.

32
Q

Confidence intervals, what are they and when are they significant?

A

Range of values in which a specified probability of means of repeated samples would be expected to fall. 95% corresponds to p=0.05. If 95% CI includes difference between two variables = 0, can’t reject null. If it includes odd ratio or relative risk = 1, can’t reject null.

33
Q

For the 95% CI, Z =

A

1.96

34
Q

For the 99% CI, Z =

A

2.58

35
Q

Primary, secondary, and tertiary disease prevention

A

Primary: prevent disease from happening. Secondary: Catch disease early on. Tertiary: reduce disability from disease.

36
Q

When is parental consent not required for minors?

A

Emergency situations, prescribing contraceptives, treating STDs, medical care of pregnancy, treating drug addiction

37
Q

Priority of surrogates

A

Spouse, adult children, parents, adult siblings, other relatives

38
Q

When do you get stranger anxiety?

A

7-9 months

39
Q

When do you get separation anxiety?

A

12-15 months

40
Q

What motor stuff are kids doing at terrible twos?

A

Jumping, standing on one foot, page turning, stacking blocks.

41
Q

When do you get core gender identity?

A

2-3 years

42
Q

Cooperative play happens at?

A

4 years

43
Q

How do you treat bedwetting?

A

vasopressin

44
Q

Principal NT in REM sleep? Inhibitor of REM sleep?

A

ACh = principal, NE inhibits.

45
Q

EEG waveforms of sleep

A

BATS Drink Blood. Beta (awake), alpha (resting), theta (light sleep), sleep spindles and K complexes (deeper sleep), delta (deepest sleep), beta (in REM)

46
Q

How is REM effected with depression?

A

Increased!

47
Q

Pathway for melatonin release

A

SCN –> NE release –> Pineal gland –> Melatonin

48
Q

Biological problem in narcolepsy

A

Lack of hypocretin I (orexin A) and hypocretin II (orexin B) from lateral hypothalamus

49
Q

Name the interviewing technique: “Tell me more”

A

Facilitation

50
Q

Name the interviewing technique: “I can imagine how that might have affected you.”

A

Empathy

51
Q

Name the interviewing technique: “So, you are telling me that you feel depressed.”

A

Reflection

52
Q

Name the interviewing technique: “Although you’re telling me you were disturbed by this trauma, you sound unaffected by it as you are describing it.”

A

Confrontation

53
Q

Name the interviewing technique: “Yes, he really hurt you. A lot of abused children have similar reactions.”

A

Support

54
Q

How do you calculate incidence?

A

New cases each year/ total susceptible population. Doesn’t take deaths into consideration, but have to subtract out people who already have disease from total population for total susceptible.

55
Q

95% of population falls between how many standard deviations of the mean?

A

1.96. So that is 2.5% above and 2.5% below. For 99%, 2.58 standard deviations, .5 above and .5 below.

56
Q

Your test has low sensitivity and high specificity. Rule out test or rule in?

A

Low sensitivity means that you aren’t good at finding positive results, and the high specificity means you are good at finding negative results. So if the test is negative, it doesn’t tell you much, but if the test is positive, you should probably believe it. Rule in.

57
Q

Screening test for Hep C has 95% sensitivity and 90% specificity. The sample is known 10% Hep C. What is the best estimate of the chance that a donor who tests negative is actually negative?

A

Asking for PVN and given specificity, sensitivity, and sample distribution. So draw out 2x2, make 10 the total for disease +, 90 the total for disease -, x/10 = .90 for sensitivity, x/90 = .95 for specificity, and then do TN/FN + TN and you are golden. Answer is 99%

58
Q

SD = 20 and there are 100 people in the study and the mean is 110. What is the confidence interval of 95%?
What is the range of scores that encapsulates 95% of people?

A

CI = mean +/- Z (SD/sqrt n). Z for 95% = 1.96, round up to 2. sqrt N = 10. SD = 20. So 2 x 2 = 4. 106-114 is the interval.
If it was asking for the scores of 95% of people who took the test, it would be 110 +/- 2 SD.